RENAL CELL CARCINOMA RECURRENT

Clinical trials for RENAL CELL CARCINOMA RECURRENT explained in plain language.

Never miss a new study

Get alerted when new RENAL CELL CARCINOMA RECURRENT trials appear

Sign up with your email to follow new studies for RENAL CELL CARCINOMA RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Can a pill that starves tumors of oxygen help fight advanced cancer?

Disease control Ongoing

This early-stage trial is testing an experimental drug called belzutifan in people with advanced solid tumors that have not responded to standard treatments. Belzutifan works by blocking a protein (HIF-2α) that tumors use to survive in low-oxygen conditions. The main goal is to f…

Matched conditions: RENAL CELL CARCINOMA RECURRENT

Phase: PHASE1 • Sponsor: Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) • Aim: Disease control

Last updated Jul 24, 2026 00:00 UTC

RENAL CELL CARCINOMA RECURRENT

Get alerted when new RENAL CELL CARCINOMA RECURRENT trials appear

Can a pill that starves tumors of oxygen help fight advanced cancer?